secwatch.observer — SEC 8-K summary
======================================

Issuer:     NIKA PHARMACEUTICALS, INC (NIKA)
CIK:        0001145604
Form:       8-K
Filed at:   2022-04-05T23:59:59+00:00
Accession:  0001826466-22-000028
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Centennial Growth Equities changes control; Savov buys 87% stake, becomes CEO
-----------------------------------------------------------------------------

- Dimitar Slavchev Savov purchased 11,489,000 shares (87%) from Phil E. Ray and other shareholders, triggering change of control on April 1, 2022.
- Phil E. Ray resigned as Director, President, and CEO; A. Terry Ray resigned as Director and Secretary; both effective March 31, 2022, with no disagreements.
- Savov and Clifford Redekop appointed Directors March 31; Savov named President, CEO, CFO; Redekop named Secretary effective April 1, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/0001826466-22-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001826466-22-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer